Red and white blood cells

Identify clonal
T-cell expansion
faster

Identify clonal
T-cell expansion
faster

Experience the future of T-cell research with Beckman Coulter Life Sciences.

As a global leader in laboratory automation and innovation, we are proud to introduce our latest breakthrough: the first commercially available anti-TRBC2 conjugated antibody.

Be among the first to test our TRBC1 and TRBC2 antibodies for your T-cell research

Fill the form to request a demo

2 parametric contour histogram of trbc1 vs trbc2 gated on cd3 positive cells

Identify clonal T-cell expansion with our TRBC1 and TRBC2 antibodies

This revolutionary development provides clinical researchers with unprecedented clarity in the identification of T-cell neoplasms, particularly in the field of cancer research.

Our TRBC1 and TRBC2 antibodies target the TCR constant β chains, which are randomly selected during T-cell development. Normal T-cell populations consist of a mix of TRBC1 and TRBC2, while clonal populations only contain one. By utilizing flow cytometry and our TRBC1 and TRBC2 conjugated antibodies, you can quickly and affordably perform a specific T-cell clonality test.

Don't miss out on this opportunity to revolutionize your T-cell research.

Sign up now for a FREE demo of our TRBC1 and TRBC2 antibodies and experience the future of T-cell clonality testing.

TRBC1 and TRBC2 are available through Custom Design Services either as a standalone conjugated antibody, or part of liquid or dry custom panel. For Research Use Only. Not for use in diagnostic procedures.

Fill out the form and your local representative will reach out to you to organize a product demonstration in your lab environment.